Home › Funds › Chescapmanager LLC › CGTX

Chescapmanager LLC position in CGTX

COGNITION THERAPEUTICS INC · Health Care

Chescapmanager LLC reported holding 997,029 shares of CGTX (COGNITION THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$957K, representing 0.16% of its reported portfolio and ranking #22 among its reported holdings. Chescapmanager LLC has disclosed CGTX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)997.03K sh
Reported value held$957.15K
Portfolio Weight0.16%
First reportedQ2 2025
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Chescapmanager LLC's CGTX position evolved

Chescapmanager LLC first disclosed a stake in CGTX in Q2 2025 at 503,259 shares (US$156K). The position peaked in Q3 2025 at 997,029 shares, worth US$1.3M. Across 6 filings, Chescapmanager LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 997,029 shares valued at US$957K. Notable position changes include a 98% increase in Q3 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 503.26K $155.91K New
Q3 2025 997.03K $1.35M Add
Q4 2025 997.03K $1.35M Hold
Q1 2026 997.03K $757.24K Hold
Q2 2026 997.03K $1.15M Hold
Q3 2026 997.03K $957.15K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CGTX and 13F data

CGTX (COGNITION THERAPEUTICS INC) is a Health Care company. 32 other funds we track also report a position in CGTX — the largest reported positions include BIOS Capital Management, LP (US$5.76B), Dauntless Investment Group, LLC (US$427K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CGTX

All CGTX fund holders →

FAQ

How long has Chescapmanager LLC held CGTX?

Chescapmanager LLC has disclosed CGTX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is Chescapmanager LLC's current position in CGTX?

As of Q3 2026, Chescapmanager LLC holds 997.03K shares of CGTX (COGNITION THERAPEUTICS INC), valued at $957.15K, representing 0.16% of its reported portfolio and ranking #22.

Has Chescapmanager LLC been buying or selling CGTX?

In the latest 13F filing (Q3 2026), Chescapmanager LLC held unchanged its position in CGTX. The position peaked in Q3 2025 at 997.03K shares.

Which other funds hold CGTX?

Other major institutional holders of CGTX include BIOS Capital Management, LP, Dauntless Investment Group, LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.